Baidu Inc. (Nasdaq: BIDU) has agreed to acquire app store 91 Wireless from Netdragon Websoft Inc. (HK: 777) for $1.85 billion in cash. www.baidu.com
Apple Inc. (Nasdaq: AAPL) has acquired Matcha.tv, a Mountain View, Calif.-based digital video recommendation engine. No financial terms were disclosed, although VentureBeat puts the pricetag at between $1 million and $1.5 million. Matcha had been seeded by Plug & Play Ventures and Media Camp. www.matcha.tv
Millennial Media (NYSE: MM) has agreed to acquire Jumptap, a Boston-based mobile ad network. The total deal is valued at approximately $225 million, mostly via 24.6 million shares of Millennial Media stock. JumpTap had raised over $120 million in VC funding from General Catalyst Partners, Summerhill Venture Partners, Valhalla Partners, Redpoint Ventures, AllianceBernstein, WPP and Keating Capital. www.jumptap.com
SafeStitch Medical Inc. (OTC BB: SFES) has agreed to merge with TransEnterix Inc., a Morrisville, N.C.–based developer of flexible devices and robotics for minimally invasive surgery. Under terms of the deal, TransEnterix would hold 65% of the combined company. TransEnterix has raised more than $70 million in VC funding from Aisling Capital, Intersouth Partners, Quaker BioVentures, SV Life Science Advisers, Synergy Life Science Partners and Parish Capital Advisors. www.transenterix.com
Carl Icahn announced via Twitter that he has a “large position” in Apple (Nasdaq: AAPL), sending the company’s shares up nearly 5%. Read more.
Mizuho Financial Group (Tokyo: 8411) is in talks to acquire a 39% stake in PT Bank Pan Indonesia (JKSE:PNBN) from Australia’s ANZ (ASX: ANZ), according to Bloomberg. www.anz.com
Rexam PLC (LSE: REX) is seeking upwards of $1 billion in a sale of its healthcare packaging business, according to Reuters. www.rexam.com
The U.S. Justice Department has filed an antitrust lawsuit to block the $11 billion merger ofAmerican Airlines and U.S. Airways. www.aa.com
Applied Optoelectronics Inc., a Sugar Land, Texas-based provider of fiber-optic networking product, has filed for a $50 million IPO. It plans to trade on the Nasdaq under ticker symbol AAOI, with Raymond James and Piper Jaffray serving as lead underwriters. The company reports a $1.3 million net loss on around $34 million in revenue for the first half of 2013. Shareholders include Technology Associates Management. www.ao-inc.com
China Commercial Credit, a Chinese microcredit lender, raised $9 million in its IPO. The company priced 1.4 million shares at $6.50 per share (middle of $6-$7 range), for an initial market cap of $67 million. It will trade on the Nasdaq under ticker symbol CCCR, while Burnham Securities served as lead underwriter. www.chinacommercialcredit.com
Envision Healthcare (f.k.a. Emergency Medical Services), a Greenwood Village, Colo.-based provider of outsourced medical services, raised $966 million in its IPO. The company priced 42 million shares at $23 per share (high end of $20-$23 range), compared to original plans to offer 35 million shares. Its initial market cap is $3.84 billion. The company will trade on the NYSE under ticker symbol EVH, while Goldman Sachs served as lead underwriter. The company is owned by Clayton Dubilier & Rice, and reports $41 million in 2012 net income on around $5.8 billion in revenue.www.envisionhealthcare.com
Fate Therapeutics, a San Diego-based stem cell biotech company focused on cellfate control, has filed for a $69 million IPO. It plans to trade on the Nasdaq under ticker symbol FATE, with Cowen & Co. and BMO Capital Markets serving as lead underwriters. The company reports a $9.1 million net loss on $762,000 in revenue for the first half of 2013. The company has raised over $42 million in VC funding from ARCH Venture Partners (16.8% pre-IPO stake), Polaris Partners (16.8%), Venrock (16.8%) and OVP Venture Partners (15.4%). www.fatetherapeutics.com
Sign up for Dan’s daily email newsletter on deals and deal-makers: GetTermSheet.com